Combining Conventional and Complementary Therapies in Integrative Oncology for Cancer Treatment
DOI:
https://doi.org/10.56294/hl2025856Keywords:
Integrative Oncology, Conventional Therapies, Complementary Therapies, Cancer Treatment, Holistic CareAbstract
To take care of the physical, social, and mental parts of cancer care, integrative oncology blends standard cancer medicines with alternative ones. This multidisciplinary method tries to improve cancer patients' general health by focusing on more than just the disease itself. It also looks at their quality of life and their ability to bounce back from tough times. Conventional cancer treatments, like surgery, chemotherapy, and radiation, try to get rid of all cancer cells. Complementary treatments, like acupuncture, plant medicine, and mindfulness-based practices, try to make it easier to deal with symptoms, lessen side effects, and speed up the healing process. Putting these two types of treatment together has gotten a lot of attention lately because of the growing interest in patient-centered results and balanced care. Conventional treatments can be very harsh and often have serious side effects that can lower the quality of life for patients. These side effects might be lessened by complementary treatments, which may also improve mental health, lower stress, and speed up the body's natural mending processes. Mindfulness-based treatments can also help people deal with the worry and stress that come with being diagnosed with cancer and going through treatment. When you use alternative therapies along with conventional treatments, you need to think carefully about how well they work and how safe they are. More and more study is showing that integrative cancer might be helpful, but it's still hard to standardize methods and find the best ways to combine treatments.
References
[1] Chen, S.; Cao, Z.; Prettner, K.; Kuhn, M.; Yang, J.; Jiao, L.; Wang, Z.; Li, W.; Geldsetzer, P.; Bärnighausen, T.; et al. Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories from 2020 to 2050. JAMA Oncol. 2023, 9, 465–472.
[2] Pramesh, C.S.; Badwe, R.A.; Bhoo-Pathy, N.; Booth, C.M.; Chinnaswamy, G.; Dare, A.J.; de Andrade, V.P.; Hunter, D.J.; Gopal, S.; Gospodarowicz, M.; et al. Priorities for cancer research in low- and middle-income countries: A global perspective. Nat. Med. 2022, 28, 649–657.
[3] Advancing Cancer Therapy. Nat. Cancer 2021, 2, 245–246.
[4] Pucci, C.; Martinelli, C.; Ciofani, G. Innovative approaches for cancer treatment: Current perspectives and new challenges. Ecancermedicalscience 2019, 13, 961.
[5] Mao, J.J.; Pillai, G.G.; Andrade, C.J.; Ligibel, J.A.; Basu, P.; Cohen, L.; Khan, I.A.; Mustian, K.M.; Puthiyedath, R.; Dhiman, K.S.; et al. Integrative oncology: Addressing the global challenges of cancer prevention and treatment. CA Cancer J. Clin. 2022, 72, 144–164.
[6] WHO. WHO Global Report on Traditional and Complementary Medicine 2019; World Health Organization: Geneva, Switzerland, 2019.
[7] WHO. WHO Traditional Medicine Strategy: 2014–2023; World Health Organization: Geneva, Switzerland, 2013.
[8] Satija, A.; Bhatnagar, S. Complementary Therapies for Symptom Management in Cancer Patients. Indian J. Palliat. Care 2017, 23, 468–479.
[9] Wu, J.; Liu, Y.; Fang, C.; Zhao, L.; Lin, L.; Lu, L. Traditional Chinese Medicine Preparation Combined Therapy May Improve Chemotherapy Efficacy: A Systematic Review and Meta-Analysis. Evid.-Based Complement. Altern. Med. 2019, 2019, 5015824.
[10] Giordano, A.; Tommonaro, G. Curcumin and Cancer. Nutrients 2019, 11, 2376.
[11] Abebe, W. Review of herbal medications with the potential to cause bleeding: Dental implications, and risk prediction and prevention avenues. EPMA J. 2019, 10, 51–64.
[12] Ng, Q.X.; Venkatanarayanan, N.; Ho, C.Y. Clinical use of Hypericum perforatum (St John’s wort) in depression: A meta-analysis. J. Affect. Disord. 2017, 210, 211–221.
[13] Canenguez Benitez, J.S.; Hernandez, T.E.; Sundararajan, R.; Sarwar, S.; Arriaga, A.J.; Khan, A.T.; Matayoshi, A.; Quintanilla, H.A.; Kochhar, H.; Alam, M.; et al. Advantages and Disadvantages of Using St. John’s Wort as a Treatment for Depression. Cureus 2022, 14, e29468.
[14] Chan, W.J.; Adiwidjaja, J.; McLachlan, A.J.; Boddy, A.V.; Harnett, J.E. Interactions between natural products and cancer treatments: Underlying mechanisms and clinical importance. Cancer Chemother. Pharmacol. 2023, 91, 103–119.
[15] Mathijssen, R.H.; Verweij, J.; de Bruijn, P.; Loos, W.J.; Sparreboom, A. Effects of St. John’s wort on irinotecan metabolism. J. Natl. Cancer Inst. 2002, 94, 1247–1249.
[16] Mwaka, A.D.; Abbo, C.; Kinengyere, A.A. Traditional and Complementary Medicine Use Among Adult Cancer Patients Undergoing Conventional Treatment in Sub-Saharan Africa: A Scoping Review on the Use, Safety and Risks. Cancer Manag. Res. 2020, 12, 3699–3712.
[17] Asiimwe, J.B.; Nagendrappa, P.B.; Atukunda, E.C.; Kamatenesi, M.M.; Nambozi, G.; Tolo, C.U.; Ogwang, P.E.; Sarki, A.M. Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis. Evid.-Based Complement. Altern. Med. 2021, 2021, 9963038.
[18] Foley, H.; Steel, A.; Cramer, H.; Wardle, J.; Adams, J. Disclosure of complementary medicine use to medical providers: A systematic review and meta-analysis. Sci. Rep. 2019, 9, 1573.
[19] Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 372, n71.
[20] Choi, J.Y.; Ji, W.; Choi, C.M.; Chung, C.; Noh, J.M.; Park, C.K.; Oh, I.J.; Yoon, H.I.; Kim, H.R.; Kim, H.Y.; et al. Awareness and Use of Complementary and Alternative Medicine in Korean Lung Cancer Patients. Tuberc. Respir. Dis. 2021, 84, 105–114.
[21] Kanimozhi, T.; Hindu, K.; Maheshvari, Y.; Khushnidha, Y.G.; Kumaravel, M.; Srinivas, K.S.; Manickavasagam, M.; Mangathayaru, K. Herbal supplement usage among cancer patients: A questionnaire-based survey. J. Cancer Res. Ther. 2021, 17, 136–141.
[22] Pandey, L.; Pasricha, R.; Joseph, D.; Ahuja, R.; Yanthan, Y.; Garg, P.K.; Gupta, M. Use of complementary and alternative medicine among patients with cancer in a sub-Himalayan state in India: An exploratory study. J. Ayurveda Integr. Med. 2021, 12, 126–130.
[23] Syed Mohammad Salleh, S.N.; Farooqui, M.; Gnanasan, S.; Karuppannan, M. Use of complementary and alternative medicines (CAM) among Malaysian cancer patients for the management of chemotherapy related side effects (CRSE). J. Complement. Integr. Med. 2021, 18, 805–812.
[24] Sarada, K.; Puthiyedath, R.; Philip, A.; Ravindran, G.C.; Pavithran, K. Prevalence of the use of traditional complementary and alternative medicine amongst cancer patients in a tertiary care center in Kerala, India. J. Ayurveda Integr. Med. 2021, 12, 359–364.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Hiren Hansraj Patadiya, Lalatendu Moharana, Abhishek Singla, Divya Sharma, Mittapalli Premchandh, Rashmi Gudur (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
